Melissa Myint, Ph.D.

Melissa Myint is Vice President, Head of Exploratory Biology at Sonata Therapeutics. Melissa brings extensive translation research experience across numerous disease areas to Sonata, where she leads a team of scientists in early discovery efforts to determine strategies for reprogramming diseased cells to become coordinators of cure.

Most recently, Melissa served as Senior Director of Research and Translational Sciences at Mana Therapeutics, where she oversaw all internal assay development activities and managed preclinical study execution across multiple CROs to deliver on two IND submissions. Prior to Mana, she held multiple roles of increasing responsibility at SQZ Biotechnologies, where she established preclinical proof-of-concept for two products in SQZ’s immuno-oncology pipeline.

Melissa received her B.S. in Chemical Engineering from Tufts University and her Ph.D. in Chemical Engineering from the University of Pennsylvania.